Search

Search Constraints

You searched for: Author/Creator Levran, A

Search Results

1. DOP63 Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease. (21st January 2022)